BillionToOne is a precision diagnostics company that develops molecular diagnostics using its proprietary molecular counting platform to improve disease detection.

Oguzhan Atay

BillionToOne

UNITY Complete

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection. 

Bridge Bank

Libertus Capital

Neotribe Ventures

500 Istanbul

Andrea Dusi

Y Combinator

Hummingbird Ventures

Four Rivers Group

Norwest Venture Partners

500 Global

TIME BioVentures

Fifty Years

Pacific 8 Ventures

Civilization Ventures

Adams Street Partners

Baillie Gifford

Metric
Company Name	BillionToOne
Symbol
MSH ID	COM:BILLIONTOONE
Market	PRIVATE
Sector	8
Industry	Healthcare & Health Services
Country	US
Stage	Series D
Employee Count	379
Website	billiontoone.com
LinkedIn	billiontoone
Founders

Metric
Market Cap	1.09B
Enterprise Value
Monthly Web Traffic	10.86K
Web Traffic Growth	0.05
Valuation
Raised Capital	130M

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:BILLIONTOONE

BillionToOne

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue